{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:51:01Z","timestamp":1795150261632,"version":"4.10.3"},"reference-count":101,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Carlos III Health Inititute","award":["CM19\/00066"],"award-info":[{"award-number":["CM19\/00066"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Prion diseases are progressive and irreversible neurodegenerative disorders with a low incidence (1.5\u20132 cases per million per year). Genetic (10\u201315%), acquired (anecdotal) and sporadic (85%) forms of the disease have been described. The clinical spectrum of prion diseases is very varied, although the most common symptoms are rapidly progressive dementia, cerebellar ataxia and myoclonus. Mean life expectancy from the onset of symptoms is 6 months. There are currently diagnostic criteria based on clinical phenotype, as well as neuroimaging biomarkers (magnetic resonance imaging), neurophysiological tests (electroencephalogram and polysomnogram), and cerebrospinal fluid biomarkers (14-3-3 protein and real-time quaking-induced conversion (RT-QuIC)). The sensitivity and specificity of some of these tests (electroencephalogram and 14-3-3 protein) is under debate and the applicability of other tests, such as RT-QuIC, is not universal. However, the usefulness of these biomarkers beyond the most frequent prion disease, sporadic Creutzfeldt\u2013Jakob disease, remains unclear. Therefore, research is being carried out on new, more efficient cerebrospinal fluid biomarkers (total tau, ratio total tau\/phosphorylated tau and neurofilament light chain) and potential blood biomarkers (neurofilament light chain, among others) to try to universalize access to early diagnosis in the case of prion diseases.<\/jats:p>","DOI":"10.3390\/medicina58040473","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T21:29:36Z","timestamp":1648416576000},"page":"473","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9709-5314","authenticated-orcid":false,"given":"Miren","family":"Altuna","sequence":"first","affiliation":[{"name":"Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau\u2014Biomedical Research Institute Sant Pau\u2014Universitat Aut\u00f2noma de Barcelona, 08041 Barcelona, Spain"},{"name":"Centre of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), 28031 Madrid, Spain"},{"name":"CITA-Alzheimer Foundation, 20009 Donostia-San Sebasti\u00e1n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2015-5857","authenticated-orcid":false,"given":"I\u00f1igo","family":"Ruiz","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Hospital de la Santa Creu i Sant Pau\u2014Biomedical Research Institute Sant Pau\u2014Universitat Aut\u00f2noma de Barcelona, 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Victoria","family":"Zelaya","sequence":"additional","affiliation":[{"name":"Department of Pathological Anatomy, Hospital Universitario de Navarra, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4179-5781","authenticated-orcid":false,"given":"Maite","family":"Mendioroz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario de Navarra, 31008 Pamplona, Spain"},{"name":"Neuroepigenetics Laboratory-Navarrabiomed, Hospital Universitario de Navarra, Universidad P\u00fablica de Navarra (UPNA), IdiSNA (Navarra Institute for Health Research), 31006 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/alz.12133","article-title":"A Prognostic Model for Overall Survival in Sporadic Creutzfeldt-Jakob Disease","volume":"16","author":"Llorens","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-444-63945-5.00013-1","article-title":"Genetic Creutzfeldt-Jakob Disease","volume":"153","author":"Ladogana","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","article-title":"Biomarkers and Diagnostic Guidelines for Sporadic Creutzfeldt-Jakob Disease","volume":"20","author":"Hermann","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/19336896.2015.1110293","article-title":"Prion Protein Scrapie and the Normal Cellular Prion Protein","volume":"10","author":"Atkinson","year":"2016","journal-title":"Prion"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/jnnp-2018-320155","article-title":"CSF Neurogranin as a Neuronal Damage Marker in CJD: A Comparative Study with AD","volume":"90","author":"Blennow","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.11138\/FNeur\/2017.32.3.153","article-title":"Quantitative, Functional MRI and Neurophysiological Markers in a Case of Gerstmann-Str\u00e4ussler-Scheinker Syndrome","volume":"32","author":"Marino","year":"2017","journal-title":"Funct. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/324414","article-title":"Huntington Disease Phenocopy Is a Familial Prion Disease","volume":"69","author":"Moore","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-444-63945-5.00011-8","article-title":"Variant Creutzfeldt-Jakob Disease","volume":"153","author":"Brandel","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.324.7352.1479","article-title":"First Hundred Cases of Variant Creutzfeldt-Jakob Disease: Retrospective Case Note Review of Early Psychiatric and Neurological Features","volume":"324","author":"Spencer","year":"2002","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.conb.2020.01.009","article-title":"Preclinical Biomarkers of Prion Infection and Neurodegeneration","volume":"61","author":"Mok","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","article-title":"Molecular Classification of Sporadic Creutzfeldt\u2013Jakob Disease","volume":"126","author":"Hill","year":"2003","journal-title":"Brain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4161\/pri.18666","article-title":"Molecular Pathogenesis of Sporadic Prion Diseases in Man","volume":"6","author":"Safar","year":"2012","journal-title":"Prion"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"585896","DOI":"10.3389\/fbioe.2020.585896","article-title":"Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies","volume":"8","author":"Ascari","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s00415-019-09537-0","article-title":"Diagnostic Value of Surrogate CSF Biomarkers for Creutzfeldt-Jakob Disease in the Era of RT-QuIC","volume":"266","author":"Baiardi","year":"2019","journal-title":"J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.clinph.2005.12.007","article-title":"EEG in Creutzfeldt-Jakob Disease","volume":"117","author":"Wieser","year":"2006","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease: Results from the Swedish Mortality Registry","volume":"71","author":"Asztely","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Figgie, M.P.J., and Appleby, B.S. (2021). Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease. Viruses, 13.","DOI":"10.3390\/v13050789"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/jnnp-2016-313501","article-title":"Quantitative EEG Parameters Correlate with the Progression of Human Prion Diseases","volume":"87","author":"Franko","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/19336896.2020.1803516","article-title":"Focal Sharp Waves Are a Specific Early-Stage Marker of the MM2-Cortical Form of Sporadic Creutzfeldt-Jakob Disease","volume":"14","author":"Matsubayashi","year":"2020","journal-title":"Prion"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4103\/0366-6999.235115","article-title":"Expert Consensus on Clinical Diagnostic Criteria for Fatal Familial Insomnia","volume":"131","author":"Wu","year":"2018","journal-title":"Chin. Med. J."},{"key":"ref_21","first-page":"1033","article-title":"Sleep Pathology in Creutzfeldt-Jakob Disease","volume":"12","author":"Kang","year":"2016","journal-title":"J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med."},{"key":"ref_22","first-page":"4209","article-title":"Clinical Manifestations and Polysomnography-Based Analysis in Nine Cases of Probable Sporadic Creutzfeldt-Jakob Disease","volume":"42","author":"Dai","year":"2021","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jnnp.2006.094821","article-title":"Neuroimaging Findings in Human Prion Disease","volume":"78","author":"Macfarlane","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102523","DOI":"10.1016\/j.nicl.2020.102523","article-title":"Multimodal MRI Staging for Tracking Progression and Clinical-Imaging Correlation in Sporadic Creutzfeldt-Jakob Disease","volume":"30","author":"Sacco","year":"2021","journal-title":"NeuroImage. Clin."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/jnnp-2017-315942","article-title":"Towards an Early Clinical Diagnosis of Sporadic CJD VV2 (Ataxic Type)","volume":"88","author":"Baiardi","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4329\/wjr.v1.i1.45","article-title":"Neuroimaging in Human Prion Disease: Searching in the Mist","volume":"1","author":"Ioannides","year":"2009","journal-title":"World J. Radiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4103\/0028-3886.181538","article-title":"A Hospital-Based Registry of Creutzfeldt-Jakob Disease: Can Neuroimaging Serve as a Surrogate Biomarker?","volume":"64","author":"Divya","year":"2016","journal-title":"Neurol. India"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp-2017-316853","article-title":"Imaging and CSF Analyses Effectively Distinguish CJD from Its Mimics","volume":"89","author":"Rudge","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00234-010-0820-4","article-title":"Diffusion-Weighted Imaging and Magnetic Resonance Spectroscopy of Sporadic Creutzfeldt-Jakob Disease: Correlation with Clinical Course","volume":"53","author":"Kim","year":"2011","journal-title":"Neuroradiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/01.WNL.0000134555.59460.5D","article-title":"Diffusion-Weighted MRI Abnormalities as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease","volume":"63","author":"Shiga","year":"2004","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1093\/brain\/awp064","article-title":"Thalamo-Striatal Diffusion Reductions Precede Disease Onset in Prion Mutation Carriers","volume":"132","author":"Lee","year":"2009","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1468-1331.2011.03570.x","article-title":"Glucose Metabolism in Sporadic Creutzfeldt-Jakob Disease: A Statistical Parametric Mapping Analysis of (18) F-FDG PET","volume":"19","author":"Kim","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(02)00172-6","article-title":"14-3-3 in the Cerebrospinal Fluid of Patients with Variant and Sporadic Creutzfeldt-Jakob Disease Measured Using Capture Assay Able to Detect Low Levels of 14-3-3 Protein","volume":"324","author":"Green","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Matsui, Y., Satoh, K., Miyazaki, T., Shirabe, S., Atarashi, R., Mutsukura, K., Satoh, A., Kataoka, Y., and Nishida, N. (2011). High Sensitivity of an ELISA Kit for Detection of the Gamma-Isoform of 14-3-3 Proteins: Usefulness in Laboratory Diagnosis of Human Prion Disease. BMC Neurol., 11.","DOI":"10.1186\/1471-2377-11-120"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.WNL.0000135153.96325.3B","article-title":"Sensitivity of 14-3-3 Protein Test Varies in Subtypes of Sporadic Creutzfeldt-Jakob Disease","volume":"63","author":"Castellani","year":"2004","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s00415-016-8209-x","article-title":"CSF Tau Proteins Reduce Misdiagnosis of Sporadic Creutzfeldt-Jakob Disease Suspected Cases with Inconclusive 14-3-3 Result","volume":"263","author":"Baldeiras","year":"2016","journal-title":"J. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Torres, M., Cartier, L., Matamala, J.M., Hern\u00e1ndez, N., Woehlbier, U., and Hetz, C. (2012). Altered Prion Protein Expression Pattern in CSF as a Biomarker for Creutzfeldt-Jakob Disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036159"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s00415-009-5163-x","article-title":"Cerebrospinal Fluid Biomarkers in Human Genetic Transmissible Spongiform Encephalopathies","volume":"256","author":"Ladogana","year":"2009","journal-title":"J. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Higuma, M., Sanjo, N., Satoh, K., Shiga, Y., Sakai, K., Nozaki, I., Hamaguchi, T., Nakamura, Y., Kitamoto, T., and Shirabe, S. (2013). Relationships between Clinicopathological Features and Cerebrospinal Fluid Biomarkers in Japanese Patients with Genetic Prion Diseases. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060003"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroscience.2016.02.057","article-title":"Sporadic Creutzfeldt-Jakob Disease Diagnostic Accuracy Is Improved by a New CSF ELISA 14-3-3\u03b3 Assay","volume":"322","author":"Baldeiras","year":"2016","journal-title":"Neuroscience"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","article-title":"Prion-Specific and Surrogate CSF Biomarkers in Creutzfeldt-Jakob Disease: Diagnostic Accuracy in Relation to Molecular Subtypes and Analysis of Neuropathological Correlates of p-Tau and A\u03b242 Levels","volume":"133","author":"Lattanzio","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.3390\/ijms12096281","article-title":"Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease","volume":"12","author":"Zanusso","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"15283","DOI":"10.1038\/srep15283","article-title":"Alternative Application of Tau Protein in Creutzfeldt-Jakob Disease Diagnosis: Improvement for Weakly Positive 14-3-3 Protein in the Laboratory","volume":"5","author":"Hyeon","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","article-title":"The Role of Cerebrospinal Fluid 14-3-3 and Other Proteins in the Diagnosis of Sporadic Creutzfeldt-Jakob Disease in the UK: A 10-Year Review","volume":"81","author":"Chohan","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.55.4.514","article-title":"14-3-3 Testing in Diagnosing Creutzfeldt-Jakob Disease: A Prospective Study in 112 Patients","volume":"55","author":"Lemstra","year":"2000","journal-title":"Neurology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s12035-015-9167-5","article-title":"Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic","volume":"53","author":"Schmitz","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","article-title":"Cerebrospinal Fluid Biomarker Supported Diagnosis of Creutzfeldt-Jakob Disease and Rapid Dementias: A Longitudinal Multicentre Study over 10 Years","volume":"135","author":"Stoeck","year":"2012","journal-title":"Brain"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000454802","article-title":"Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs","volume":"43","author":"Llorens","year":"2017","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.0b013e318263565f","article-title":"A Comparison of Tau and 14-3-3 Protein in the Diagnosis of Creutzfeldt-Jakob Disease","volume":"79","author":"Hamlin","year":"2012","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Coulthart, M.B., Jansen, G.H., Olsen, E., Godal, D.L., Connolly, T., Choi, B.C.K., Wang, Z., and Cashman, N.R. (2011). Diagnostic Accuracy of Cerebrospinal Fluid Protein Markers for Sporadic Creutzfeldt-Jakob Disease in Canada: A 6-Year Prospective Study. BMC Neurol., 11.","DOI":"10.1186\/1471-2377-11-133"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"116971","DOI":"10.1016\/j.jns.2020.116971","article-title":"An Automated Alert System Based on the P-Tau\/Tau Ratio to Quickly Inform Health Professionals upon a Suspected Case of Sporadic Creutzfeldt-Jakob Disease","volume":"415","author":"Delaye","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00415-019-09610-8","article-title":"Cerebrospinal Fluid Non-Phosphorylated Tau in the Differential Diagnosis of Creutzfeldt-Jakob Disease: A Comparative Prospective Study with 14-3-3","volume":"267","author":"Llorens","year":"2020","journal-title":"J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00415-010-5738-6","article-title":"Tau and 14-3-3 of Genetic and Sporadic Creutzfeldt-Jakob Disease Patients in Israel","volume":"258","author":"Meiner","year":"2011","journal-title":"J. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/ene.12991","article-title":"Cerebrospinal Fluid Markers in the Differentiation of Molecular Subtypes of Sporadic Creutzfeldt-Jakob Disease","volume":"23","author":"Heinemann","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.neurobiolaging.2015.01.021","article-title":"Cerebrospinal Fluid Tau Levels Are a Marker for Molecular Subtype in Sporadic Creutzfeldt-Jakob Disease","volume":"36","author":"Karch","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-160267","article-title":"Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia","volume":"54","author":"Karch","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000101339","article-title":"Chronological Changes in MRI and CSF Biochemical Markers in Creutzfeldt-Jakob Disease Patients","volume":"23","author":"Satoh","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2016.10.012","article-title":"CSF Tau Correlates with the Degree of Cortical Involvement in E200K Familial Creutzfeldt-Jakob Disease","volume":"634","author":"Cohen","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","article-title":"A Prospective Study of CSF Markers in 250 Patients with Possible Creutzfeldt-Jakob Disease","volume":"74","author":"Quoilin","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MAJ.0b013e3181e92a1f","article-title":"Elevated Levels of Tau Protein in Cerebrospinal Fluid of Patients with Probable Creutzfeldt-Jakob Disease","volume":"340","author":"Wang","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mcn.2018.12.003","article-title":"Review: Fluid Biomarkers in the Human Prion Diseases","volume":"97","author":"Thompson","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jalz.2017.12.008","article-title":"Cerebrospinal Fluid Neurofilament Light Levels in Neurodegenerative Dementia: Evaluation of Diagnostic Accuracy in the Differential Diagnosis of Prion Diseases","volume":"14","author":"Zerr","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_63","first-page":"124","article-title":"Cerebrospinal Fluid Neurofilament Light in Suspected Sporadic Creutzfeldt-Jakob Disease","volume":"60","author":"Kanata","year":"2019","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","article-title":"The CSF Neurofilament Light Signature in Rapidly Progressive Neurodegenerative Dementias","volume":"10","author":"Capellari","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00415-015-7837-x","article-title":"Quantification of CSF Biomarkers Using an Electrochemiluminescence-Based Detection System in the Differential Diagnosis of AD and SCJD","volume":"262","author":"Llorens","year":"2015","journal-title":"J. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2016.09.013","article-title":"Evaluation of \u03b1-Synuclein as a Novel Cerebrospinal Fluid Biomarker in Different Forms of Prion Diseases","volume":"13","author":"Llorens","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1074\/mcp.M116.059915","article-title":"Alpha-, Beta-, and Gamma-Synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer\u2019s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies","volume":"15","author":"Oeckl","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_68","first-page":"e12214","article-title":"Diagnostic and Prognostic Performance of CSF \u03b1-Synuclein in Prion Disease in the Context of Rapidly Progressive Dementia","volume":"13","author":"Mastrangelo","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Abu-Rumeileh, S., Oeckl, P., Baiardi, S., Halbgebauer, S., Steinacker, P., Capellari, S., Otto, M., and Parchi, P. (2020). CSF Ubiquitin Levels Are Higher in Alzheimer\u2019s Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease. Biomolecules, 10.","DOI":"10.3390\/biom10040497"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pmic.200900246","article-title":"Ubiquitin as Potential Cerebrospinal Fluid Marker of Creutzfeldt-Jakob Disease","volume":"10","author":"Steinacker","year":"2010","journal-title":"Proteomics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/ene.14655","article-title":"Calmodulin Level Is Significantly Increased in the Cerebrospinal Fluid of Patients with Sporadic Creutzfeldt-Jakob Disease","volume":"28","author":"Chen","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.18632\/aging.101101","article-title":"Regulation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 in Sporadic Creutzfeldt-Jakob Disease Patients","volume":"8","author":"Schmitz","year":"2016","journal-title":"Aging"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zerr, I., Villar-Piqu\u00e9, A., Schmitz, V.E., Poleggi, A., Pocchiari, M., S\u00e1nchez-Valle, R., Calero, M., Calero, O., Baldeiras, I., and Santana, I. (2019). Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients. Biomolecules, 9.","DOI":"10.3390\/biom9120800"},{"key":"ref_74","first-page":"2","article-title":"CSF Biomarkers of Neuroinflammation in Distinct Forms and Subtypes of Neurodegenerative Dementia","volume":"12","author":"Steinacker","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/pr800832s","article-title":"Prion Disease Diagnosis by Proteomic Profiling","volume":"8","author":"Herbst","year":"2009","journal-title":"J. Proteome Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24833","article-title":"Diagnostic and Prognostic Value of Human Prion Detection in Cerebrospinal Fluid","volume":"81","author":"Foutz","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sano, K., Satoh, K., Atarashi, R., Takashima, H., Iwasaki, Y., Yoshida, M., Sanjo, N., Murai, H., Mizusawa, H., and Schmitz, M. (2013). Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054915"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","article-title":"Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction between Alzheimer Disease and Creutzfeldt-Jakob Disease","volume":"72","author":"Dorey","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Vallabh, S.M., Minikel, E.V., Williams, V.J., Carlyle, B.C., McManus, A.J., Wennick, C.D., Bolling, A., Trombetta, B.A., Urick, D., and Nobuhara, C.K. (2020). Cerebrospinal Fluid and Plasma Biomarkers in Individuals at Risk for Genetic Prion Disease. BMC Med., 18.","DOI":"10.1186\/s12916-020-01608-8"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s12035-018-1251-1","article-title":"Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases","volume":"56","author":"Schmitz","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","article-title":"Diagnosis of Prion Diseases by RT-QuIC Results in Improved Surveillance","volume":"95","author":"Rhoads","year":"2020","journal-title":"Neurology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e00769-19","DOI":"10.1128\/JCM.00769-19","article-title":"Clinical Laboratory Tests Used to Aid in Diagnosis of Human Prion Disease","volume":"57","author":"Connor","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive Human Prion Detection in Cerebrospinal Fluid by Real-Time Quaking-Induced Conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Piconi, G., Peden, A.H., Barria, M.A., and Green, A.J.E. (2019). Epitope Mapping of the Protease Resistant Products of RT-QuIC Does Not Allow the Discrimination of SCJD Subtypes. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218509"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s12035-017-0479-5","article-title":"Validation of \u03b1-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease","volume":"55","author":"Llorens","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4939-7244-9_14","article-title":"RT-QuIC Assays for Prion Disease Detection and Diagnostics","volume":"1658","author":"Groveman","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13195-021-00815-6","article-title":"Diagnostic and Prognostic Value of Plasma Neurofilament Light and Total-Tau in Sporadic Creutzfeldt-Jakob Disease","volume":"13","author":"Zerr","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"38737","DOI":"10.1038\/srep38737","article-title":"Neurofilaments in Blood and CSF for Diagnosis and Prediction of Onset in Creutzfeldt-Jakob Disease","volume":"6","author":"Steinacker","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jnnp-2020-323826","article-title":"Comparison between Plasma and Cerebrospinal Fluid Biomarkers for the Early Diagnosis and Association with Survival in Prion Disease","volume":"91","author":"Baiardi","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1038\/s41380-021-01045-w","article-title":"Evaluation of Plasma Tau and Neurofilament Light Chain Biomarkers in a 12-Year Clinical Cohort of Human Prion Diseases","volume":"26","author":"Thompson","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"648743","DOI":"10.3389\/fnins.2021.648743","article-title":"Cerebrospinal Fluid and Blood Neurofilament Light Chain Protein in Prion Disease and Other Rapidly Progressive Dementias: Current State of the Art","volume":"15","author":"Parchi","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/jnnp-2017-317793","article-title":"Neurofilament Light Chain and Tau Concentrations Are Markedly Increased in the Serum of Patients with Sporadic Creutzfeldt-Jakob Disease, and Tau Correlates with Rate of Disease Progression","volume":"89","author":"Thompson","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00415-011-5960-x","article-title":"Serum Tau Protein as a Marker for the Diagnosis of Creutzfeldt-Jakob Disease","volume":"258","author":"Hamaguchi","year":"2011","journal-title":"J. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12974-019-1531-3","article-title":"Plasma YKL-40 in the Spectrum of Neurodegenerative Dementia","volume":"16","author":"Schmitz","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1038\/s41467-020-17655-x","article-title":"A Blood MiRNA Signature Associates with Sporadic Creutzfeldt-Jakob Disease Diagnosis","volume":"11","author":"Norsworthy","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/nan.12573","article-title":"Plasma Total Prion Protein as a Potential Biomarker for Neurodegenerative Dementia: Diagnostic Accuracy in the Spectrum of Prion Diseases","volume":"46","author":"Llorens","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13760-018-0995-8","article-title":"A Systematic Review Comparing the Diagnostic Value of 14-3-3 Protein in the Cerebrospinal Fluid, RT-QuIC and RT-QuIC on Nasal Brushing in Sporadic Creutzfeldt-Jakob Disease","volume":"118","author":"Behaeghe","year":"2018","journal-title":"Acta Neurol. Belg."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3233\/JAD-170770","article-title":"Translational Research in Alzheimer\u2019s and Prion Diseases","volume":"62","author":"Giaccone","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-P\u00e9rez, \u00d3., Sanz-Rubio, D., Hernaiz, A., Betancor, M., Otero, A., Castilla, J., Andr\u00e9oletti, O., Badiola, J.J., Zaragoza, P., and Bolea, R. (2021). Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and MiRNAs as Biomarkers for Prion Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136822"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Vassileff, N., Cheng, L., and Hill, A.F. (2020). Extracellular Vesicles\u2014Propagators of Neuropathology and Sources of Potential Biomarkers and Therapeutics for Neurodegenerative Diseases. J. Cell Sci., 133.","DOI":"10.1242\/jcs.243139"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1212\/WNL.0000000000007745","article-title":"Age at Onset in Genetic Prion Disease and the Design of Preventive Clinical Trials","volume":"93","author":"Minikel","year":"2019","journal-title":"Neurology"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/4\/473\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:43:41Z","timestamp":1760136221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/4\/473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":101,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["medicina58040473"],"URL":"https:\/\/doi.org\/10.3390\/medicina58040473","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202202.0308.v1","asserted-by":"object"}]},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]}}}